ALLE vs TTRX · P/E 21, rev $2.19B vs $187.1M cap
Allegion PLC (ALLE) versus Turn Therapeutics Inc. Common Stock (TTRX) — a side-by-side from cached financials, not a winner call.
Allegion PLC (ALLE) is a security & protection services company listed on US.
Turn Therapeutics Inc. Common Stock (TTRX) is a biotechnology company listed on NASDAQ.
Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
TTRX does not have a complete income-statement cache yet.
ALLE currently screens at market cap $12.71B and trailing P/E 20.7. TTRX currently screens at market cap $187.1M.
Not investment advice. Open the ALLE and TTRX stock pages for the full models.
Not investment advice.